Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Pseudohypoaldosteronism type II (PHAII) is an autosomal dominant disorder of hyperkalemia and hypertension. Mutations in two members of the WNK kinase family, WNK1 and WNK4, cause the disease. WNK1 mutations are believed to increase WNK1 expression; the effect of WNK4 mutations remains unknown. The clinical phenotype of PHAII is opposite to Gitelman syndrome, a disease caused by dysfunction of the thiazide-sensitive Na-Cl cotransporter. We tested the hypothesis that WNK kinases regulate the mammalian thiazide-sensitive Na-Cl cotransporter (NCC). Mouse WNK4 was cloned and expressed in Xenopus oocytes with or without NCC. Coexpression with WNK4 suppressed NCC activity by more than 85%. This effect did not result from defects in NCC synthesis or processing, but was associated with an 85% reduction in NCC abundance at the plasma membrane. Unlike WNK4, WNK1 did not affect NCC activity directly. WNK1, however, completely prevented WNK4 inhibition of NCC. Some WNK4 mutations that cause PHAII retained NCC-inhibiting activity, but the Q562E WNK4 demonstrated diminished activity, suggesting that some PHAII mutations lead to loss of NCC inhibition. Gain-of-function WNK1 mutations would be expected to inhibit WNK4 activity, thereby activating NCC, contributing to the PHAII phenotype. Together, these results identify WNK kinases as a previously unrecognized sodium regulatory pathway of the distalnephron. This pathway likely contributes to normal and pathological blood pressure homeostasis.
Appel,
The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension.
2002, Pubmed
Appel,
The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension.
2002,
Pubmed
Bachmann,
Sodium transport-related proteins in the mammalian distal nephron - distribution, ontogeny and functional aspects.
1999,
Pubmed
Bostanjoglo,
11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules.
1998,
Pubmed
Chiu,
Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions.
2002,
Pubmed
De Jong,
Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome.
2002,
Pubmed
,
Xenbase
Ellison,
Thiazide-sensitive sodium chloride cotransport in early distal tubule.
1987,
Pubmed
Gamba,
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter.
1993,
Pubmed
,
Xenbase
Gamba,
Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney.
1994,
Pubmed
,
Xenbase
Hayes,
Role of N-linked glycosylation in rat renal Na/Pi-cotransport.
1994,
Pubmed
,
Xenbase
Kunchaparty,
Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome.
1999,
Pubmed
,
Xenbase
Levy,
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study.
2000,
Pubmed
Loffing,
Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron.
2001,
Pubmed
Mayan,
Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
2002,
Pubmed
Monroy,
Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a new model for ions and diuretics interaction.
2000,
Pubmed
,
Xenbase
Quilty,
Impaired trafficking of distal renal tubular acidosis mutants of the human kidney anion exchanger kAE1.
2002,
Pubmed
Reilly,
Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy.
2000,
Pubmed
Rossier,
Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?
2003,
Pubmed
Schambelan,
Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
1981,
Pubmed
Simon,
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.
1996,
Pubmed
Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed
Xu,
WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.
2000,
Pubmed
Xu,
Regulation of WNK1 by an autoinhibitory domain and autophosphorylation.
2002,
Pubmed
Xu,
Genome-wide detection of tissue-specific alternative splicing in the human transcriptome.
2002,
Pubmed
